Brain-derived neurotrophic factor and schizophrenia
Open Access
- 1 November 2016
- journal article
- Published by College of Psychiatric and Neurologic Pharmacists (CPNP) in Mental Health Clinician
- Vol. 6 (6), 285-288
- https://doi.org/10.9740/mhc.2016.11.285
Abstract
Schizophrenia is a severe disorder affecting approximately 1% of the population. Historically, alterations of dopaminergic function were considered the primary cause of schizophrenia. However, for many patients, drugs that alter dopaminergic function do not consistently lead to resolution of the symptoms of schizophrenia. Thus, there is an increased interest in pathophysiologic processes that result in altered neurodevelopment and plasticity associated with schizophrenia. Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neurogenesis, synaptic plasticity, cognition, and neurotransmission. Genetic polymorphism, expression, and function of BDNF have been implicated in psychiatric diseases, including schizophrenia. This review discusses BDNF, its role in neurologic processes, and the evidence implicating BDNF in schizophrenia.Keywords
This publication has 41 references indexed in Scilit:
- Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic reviewWorld Journal of Psychiatry, 2015
- BDNF and Schizophrenia: From Neurodevelopment to Neuronal Plasticity, Learning, and MemoryFrontiers in Psychiatry, 2013
- The role of BDNF in the pathophysiology and treatment of schizophreniaJournal of Psychiatric Research, 2012
- Brain-derived neurotrophic factor: findings in schizophreniaCurrent Opinion in Psychiatry, 2011
- Phencyclidine (PCP)-Induced Disruption in Cognitive Performance is Gender-Specific and Associated with a Reduction in Brain-Derived Neurotrophic Factor (BDNF) in Specific Regions of the Female Rat BrainJournal of Molecular Neuroscience, 2010
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysisMolecular Psychiatry, 2010
- Glutamate and Neurotrophic Factors in Neuronal Plasticity and DiseaseAnnals of the New York Academy of Sciences, 2008
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaThe New England Journal of Medicine, 2005
- BDNF in schizophrenia, depression and corresponding animal modelsMolecular Psychiatry, 2005
- Inhibition of GABAASynaptic Responses by Brain-Derived Neurotrophic Factor (BDNF) in Rat HippocampusJournal of Neuroscience, 1997